Cargando…

Effect of body mass index on survival of patients with stage I non-small cell lung cancer

BACKGROUND: Body mass index (BMI) has a U-shaped association with lung cancer risk. However, the effect of BMI on prognosis is controversial. This retrospective study aimed to investigate the effect of BMI on the survival of patients with stage I non-small cell lung cancer (NSCLC) after surgical res...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Hao-Jun, Zhang, Xu, Wei, Zhen-Qiang, Long, Hao, Rong, Tie-Hua, Su, Xiao-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223575/
https://www.ncbi.nlm.nih.gov/pubmed/28069048
http://dx.doi.org/10.1186/s40880-016-0170-7
_version_ 1782493196348030976
author Xie, Hao-Jun
Zhang, Xu
Wei, Zhen-Qiang
Long, Hao
Rong, Tie-Hua
Su, Xiao-Dong
author_facet Xie, Hao-Jun
Zhang, Xu
Wei, Zhen-Qiang
Long, Hao
Rong, Tie-Hua
Su, Xiao-Dong
author_sort Xie, Hao-Jun
collection PubMed
description BACKGROUND: Body mass index (BMI) has a U-shaped association with lung cancer risk. However, the effect of BMI on prognosis is controversial. This retrospective study aimed to investigate the effect of BMI on the survival of patients with stage I non-small cell lung cancer (NSCLC) after surgical resection. METHODS: In total, 624 consecutive stage I NSCLC patients who underwent radical resection were classified into four groups according to their BMI: underweight (BMI < 18.5 kg/m(2)), normal weight (BMI = 18.5–22.4 kg/m(2)), overweight (BMI = 22.5–28.0 kg/m(2)), and obese (BMI > 28.0 kg/m(2)). The effect of BMI on progression-free survival (PFS) and overall survival (OS) was estimated using the Kaplan–Meier method and Cox proportional hazards model. Postoperative complications in each group were analyzed using the Chi square test or Fisher’s exact test. RESULTS: A univariate analysis showed that PFS and OS were longer in the overweight group than in other groups (both P < 0.05). A multivariate analysis showed that OS was longer in the overweight group than in other groups (compared with the other three groups in combination: hazard ratio [HR] = 1.87, 95% confidence interval [CI] 1.30–2.68, P = 0.003; compared with the underweight group: HR = 2.24, 95% CI 1.18–4.25, P = 0.013; compared with the normal weight group: HR = 1.58, 95% CI 1.07–2.33, P = 0.022; compared with the obese group: HR = 2.87, 95% CI 1.48–5.59, P = 0.002), but PFS was similar among the groups (HR = 1.28, 95% CI 0.97–1.68, P = 0.080). A subgroup analysis showed an association between being overweight and prolonged OS in patients at stage T1a (P = 0.024), T1b (P = 0.051), and T2a (P = 0.02), as well as in patients with a non-smoking history (P = 0.001). Overweight patients had lower rates of postoperative complications, such as respiratory failure (compared with the underweight and obese groups: P = 0.014), myocardial infarction (compared with the obese group: P = 0.033), and perioperative death (compared with the other three groups: P = 0.016). CONCLUSIONS: Preoperative BMI is an independent prognostic factor for stage I NSCLC patients after resection, with overweight patients having a favorable prognosis.
format Online
Article
Text
id pubmed-5223575
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52235752017-01-11 Effect of body mass index on survival of patients with stage I non-small cell lung cancer Xie, Hao-Jun Zhang, Xu Wei, Zhen-Qiang Long, Hao Rong, Tie-Hua Su, Xiao-Dong Chin J Cancer Original Article BACKGROUND: Body mass index (BMI) has a U-shaped association with lung cancer risk. However, the effect of BMI on prognosis is controversial. This retrospective study aimed to investigate the effect of BMI on the survival of patients with stage I non-small cell lung cancer (NSCLC) after surgical resection. METHODS: In total, 624 consecutive stage I NSCLC patients who underwent radical resection were classified into four groups according to their BMI: underweight (BMI < 18.5 kg/m(2)), normal weight (BMI = 18.5–22.4 kg/m(2)), overweight (BMI = 22.5–28.0 kg/m(2)), and obese (BMI > 28.0 kg/m(2)). The effect of BMI on progression-free survival (PFS) and overall survival (OS) was estimated using the Kaplan–Meier method and Cox proportional hazards model. Postoperative complications in each group were analyzed using the Chi square test or Fisher’s exact test. RESULTS: A univariate analysis showed that PFS and OS were longer in the overweight group than in other groups (both P < 0.05). A multivariate analysis showed that OS was longer in the overweight group than in other groups (compared with the other three groups in combination: hazard ratio [HR] = 1.87, 95% confidence interval [CI] 1.30–2.68, P = 0.003; compared with the underweight group: HR = 2.24, 95% CI 1.18–4.25, P = 0.013; compared with the normal weight group: HR = 1.58, 95% CI 1.07–2.33, P = 0.022; compared with the obese group: HR = 2.87, 95% CI 1.48–5.59, P = 0.002), but PFS was similar among the groups (HR = 1.28, 95% CI 0.97–1.68, P = 0.080). A subgroup analysis showed an association between being overweight and prolonged OS in patients at stage T1a (P = 0.024), T1b (P = 0.051), and T2a (P = 0.02), as well as in patients with a non-smoking history (P = 0.001). Overweight patients had lower rates of postoperative complications, such as respiratory failure (compared with the underweight and obese groups: P = 0.014), myocardial infarction (compared with the obese group: P = 0.033), and perioperative death (compared with the other three groups: P = 0.016). CONCLUSIONS: Preoperative BMI is an independent prognostic factor for stage I NSCLC patients after resection, with overweight patients having a favorable prognosis. BioMed Central 2017-01-10 /pmc/articles/PMC5223575/ /pubmed/28069048 http://dx.doi.org/10.1186/s40880-016-0170-7 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Article
Xie, Hao-Jun
Zhang, Xu
Wei, Zhen-Qiang
Long, Hao
Rong, Tie-Hua
Su, Xiao-Dong
Effect of body mass index on survival of patients with stage I non-small cell lung cancer
title Effect of body mass index on survival of patients with stage I non-small cell lung cancer
title_full Effect of body mass index on survival of patients with stage I non-small cell lung cancer
title_fullStr Effect of body mass index on survival of patients with stage I non-small cell lung cancer
title_full_unstemmed Effect of body mass index on survival of patients with stage I non-small cell lung cancer
title_short Effect of body mass index on survival of patients with stage I non-small cell lung cancer
title_sort effect of body mass index on survival of patients with stage i non-small cell lung cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223575/
https://www.ncbi.nlm.nih.gov/pubmed/28069048
http://dx.doi.org/10.1186/s40880-016-0170-7
work_keys_str_mv AT xiehaojun effectofbodymassindexonsurvivalofpatientswithstageinonsmallcelllungcancer
AT zhangxu effectofbodymassindexonsurvivalofpatientswithstageinonsmallcelllungcancer
AT weizhenqiang effectofbodymassindexonsurvivalofpatientswithstageinonsmallcelllungcancer
AT longhao effectofbodymassindexonsurvivalofpatientswithstageinonsmallcelllungcancer
AT rongtiehua effectofbodymassindexonsurvivalofpatientswithstageinonsmallcelllungcancer
AT suxiaodong effectofbodymassindexonsurvivalofpatientswithstageinonsmallcelllungcancer